Polydatin ameliorates ovalbumin‐induced asthma in a rat model through NCOA4 ‐mediated ferroautophagy and ferroptosis pathway
FEBS Open Bio · 2025
DOI: 10.1002/2211-5463.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Wei Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China. Hauptthemen laut MEDLINE: Asthma, Ferroptosis, Autophagy, Stilbenes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Plan Project of Hebei Provincial Administration of Traditional Chinese Medicine, the Innovation Grant Program for Graduate Students of Hebei University of Traditional Chinese Medicine, Innovation ability training for postgraduates of the Education Department of Hebei Province.
Abstract (Originalsprache)
Asthma is one of the most prevalent chronic diseases worldwide. In this study, we aimed to explore whether polydatin can achieve therapeutic effects in experimental asthma in a rat model by suppressing ferroptosis and its potential mechanism of inhibiting ferroptosis. We established a rat asthma model, and five experimental groups were established: the control group, model group, polydatin group, 3‐MA group, and Fer‐1 group. We compared general conditions, behavioral changes, Fe 3+ deposition, pathological changes, pulmonary function, serum IgE levels, ferroautophagy‐related genes, and ferroptosis‐related genes expression among the groups. Following the polydatin intervention, the mental state of the rats stabilized, their fur condition improved, and both food intake and body weight increased. The incubation period of asthma lengthened, and they sneezed and scratched less frequently. Additionally, polydatin reduced serum IgE levels and Fe 3+ deposition, enhanced lung function and pathological alterations, and also downregulated the expression of nuclear receptor coactivator 4 (NCOA4), Bcl‐2 homologous domain protein (Beclin1), Fe 2+ , malondialdehyde (MDA), and 4‐hydroxynonenal (4‐HNE) in lung tissue. Levels of ferritin heavy chain 1 (FTH1), ubiquitin‐binding protein p62 (P62), glutathione (GSH), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11) were all upregulated. In conclusion, in this rat model, polydatin was capable of reducing Fe 2+ overload by inhibiting the NCOA4‐mediated ferroautophagy. This, in turn, inhibited ferroptosis in the lung tissues, thereby alleviating asthma symptoms. Further studies, including clinical trials, are required to validate this result.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
- Hebei Key Laboratory of Integrated Chinese and Western Medicine for Lung Disease Research, Shijiazhuang, China.
ORCID-Profile: Chaoyi Fang
Förderung
- Research Plan Project of Hebei Provincial Administration of Traditional Chinese Medicine
- the Innovation Grant Program for Graduate Students of Hebei University of Traditional Chinese Medicine
- Innovation ability training for postgraduates of the Education Department of Hebei Province
Zitieren
APA
Li, W., Tang, Y., Liu, W., Fang, F., Wang, J., & Fang, C. (2025). Polydatin ameliorates ovalbumin‐induced asthma in a rat model through NCOA4 ‐mediated ferroautophagy and ferroptosis pathway. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70090
Vancouver
Li W, Tang Y, Liu W, Fang F, Wang J, Fang C. Polydatin ameliorates ovalbumin‐induced asthma in a rat model through NCOA4 ‐mediated ferroautophagy and ferroptosis pathway. FEBS Open Bio. 2025. doi:10.1002/2211-5463.70090
BibTeX
@article{Li2025,
author = {Li, Wei and Tang, Yuwei and Liu, Wenkang and Fang, Fang and Wang, Jiepeng and Fang, Chaoyi},
title = {Polydatin ameliorates ovalbumin‐induced asthma in a rat model through NCOA4 ‐mediated ferroautophagy and ferroptosis pathway},
journal = {FEBS Open Bio},
year = {2025},
doi = {10.1002/2211-5463.70090}
}
EUVIMED